Cargando…
Host immune response to anti-cancer camptothecin conjugated cyclodextrin-based polymers
INTRODUCTION: Efficacy and safety are critical concerns when designing drug carriers. Nanoparticles are a particular type of carrier that has gained recent attention in cancer therapeutics. METHODS: In this study, we assess the safety profile of IT-101, a nanoparticle formed by self-assembly of camp...
Autores principales: | Chen, Yi-Fan, Wang, Yen-Hsin, Lei, Cing-Syuan, Changou, Chun A., Davis, Mark E., Yen, Yun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6806548/ https://www.ncbi.nlm.nih.gov/pubmed/31647037 http://dx.doi.org/10.1186/s12929-019-0583-0 |
Ejemplares similares
-
Formation of nanoparticles by cooperative inclusion between (S)-camptothecin-modified dextrans and β-cyclodextrin polymers
por: Nielsen, Thorbjørn Terndrup, et al.
Publicado: (2015) -
Efficiency of newly formulated camptothecin with β-cyclodextrin-EDTA-Fe(3)O(4) nanoparticle-conjugated nanocarriers as an anti-colon cancer (HT29) drug
por: Krishnan, Poorani, et al.
Publicado: (2017) -
Synthesis and Evaluation of Camptothecin Antibody–Drug
Conjugates
por: Li, Wei, et al.
Publicado: (2019) -
A phase I and pharmacokinetic study of MAG-CPT, a water-soluble polymer conjugate of camptothecin
por: Schoemaker, N E, et al.
Publicado: (2002) -
Anti-tumor effects of P-LPK-CPT, a peptide-camptothecin conjugate, in colorectal cancer
por: Hou, Lidan, et al.
Publicado: (2022)